About Parexel
Parexel is a leading global contract research organization (CRO) that provides comprehensive biopharmaceutical services spanning the entire drug development lifecycle. The company delivers end-to-end solutions from portfolio optimization and early phase clinical trials through Phase I-IV studies, regulatory submissions, market access planning, and post-approval lifecycle management. Parexel combines operational expertise with its proprietary ParexelAI technology suite to accelerate clinical development with greater speed, quality, and efficiency. The company specializes in multiple therapeutic areas including oncology, neuroscience, immunology, infectious diseases, hematology, ophthalmology, and rare diseases. Parexel's services encompass clinical trial management, regulatory strategy and submissions, real-world evidence generation, pharmacovigilance, medical communications, and market access consulting. With a team that includes more than 80 former regulatory agency professionals and access to nearly 2,500 clinical trial sites globally, Parexel serves pharmaceutical companies, biotech firms, and medical device manufacturers. The company offers flexible delivery models including functional service provider (FSP) arrangements and customized site solutions. Parexel's integrated approach combines clinical, regulatory, and market access expertise to optimize development strategies, accelerate patient enrollment, ensure regulatory compliance, and maximize the commercial potential of new therapies throughout their lifecycle.
Clinical Focus
Medical conditions and clinical areas addressed by Parexel.
Who It Serves
Milestones & Awards
Recent Milestones
ParexelAI platform launch and integration with Paradigm for AI-enabled clinical development
Awards & Recognition
Described as 'leading Oncology CRO' and 'leading neuroscience CRO'
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.